![Michael Bigham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bigham
Director/Board Member at
TeneoBio, Inc.
Profile
Founder of Magellan Diagnostics, Inc., Michael F. Bigham is a businessperson who has been at the helm of 6 different companies and presently is Executive Chairman at Paratek Pharmaceuticals, Inc. He is also on the board of Adamas Pharmaceuticals, Inc., Inmediata Health Group (former Chairman), inMediata Corp. and Frazier Lifesciences Acquisition Corp. In the past he held the position of Chief Financial Officer & Executive VP-Operations at Gilead Sciences, Inc., Executive Partner at Abingworth Management Ltd. and Partner at Abingworth LLP (a subsidiary of Abingworth Management Ltd.), Chairman & Chief Executive Officer of Paratek Pharmaceuticals, Inc., Chairman for Magellan Diagnostics, Inc., Director at Avila Therapeutics, Inc., President & Chief Executive Officer at Coulter Pharmaceuticals, Inc. and Partner & Co-Head-Healthcare Investment Banking at Hambrecht & Quist Group, Inc. He received an undergraduate degree from the University of Virginia and an MBA from Stanford University.
Michael Bigham active positions
| Companies | Position | Start |
|---|---|---|
TeneoBio, Inc.
 TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Director/Board Member | - |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Director/Board Member | - |
Former positions of Michael Bigham
| Companies | Position | End |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Chief Executive Officer | 2019-06-24 |
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 2021-11-23 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 2015-10-31 |
| SUPERNUS PHARMACEUTICALS, INC. | Director/Board Member | 2013-12-22 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Chief Executive Officer | 2011-12-31 |
Training of Michael Bigham
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
27
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 27 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Inmediata Health Group
 Inmediata Health Group Electronic Production EquipmentElectronic Technology Offers electronic solutions for enhancing the efficiency and the quality of health and dental care | Electronic Technology |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
inMediata Corp.
 inMediata Corp. Regional BanksFinance Provides payment reconciliation solutions | Finance |
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Health Technology |
Magellan Biosciences, Inc.
 Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Michael Bigham
